This Article Full Text Full Text (PDF) Methods Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bellomo, D. Articles by Kay, G. F. Search for Related Content PubMed PubMed Citation Articles by Bellomo, D. Articles by Kay, G. F. Pubmed/NCBI databases Gene GEO Profiles HomoloGene OMIM UniGene Medline Plus Health Information Congenital Heart Defects Related Collections Angiogenesis Genetically altered mice Growth factors/cytokines Ischemic biology - basic studies Cardiac development

(Circulation Research. 2000;86:e29.)
© 2000 American Heart Association, Inc.

UltraRapid Communications

Mice Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From Cardiac Ischemia

Daniela Bellomo, John P. Headrick, Ginters U. Silins, Carol A. Paterson, Penny S. Thomas, Michael Gartside, Arne Mould, Marian M. Cahill, Ian D. Tonks, Sean M. Grimmond, Steve Townson, Christine Wells, Melissa Little, Margaret C. Cummings, Nicholas K. Hayward, Graham F. Kay

From the QCF Transgenic Laboratory and Human Genetics Laboratory, Joint Experimental Oncology Program, the Queensland Institute of Medical Research (D.B., G.U.S., C.A.P., M.G., A.M., M.M.C., I.D.T., S.M.G., S.T., N.K.H., G.F.K.), and the Department of Pathology, University of Queensland (M.C.C.), Brisbane, Australia; Griffith University (J.P.H.), Gold Coast Campus, Southport, Australia; Department of Cardiothoracic Surgery (P.S.T.), Imperial College School of Medicine, National Heart and Lung Institute, London, UK; and Centre for Molecular and Cellular Biology (C.W., M.L.), University of Queensland, Brisbane, Australia.

Correspondence to Graham Kay, Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia. E-mail grahamK{at}qimr.edu.au

Abstract—Vascular endothelial growth factor-B (VEGF-B) is closely related to VEGF-A, an effector of blood vessel growth during development and disease and a strong candidate for angiogenic therapies. To further study the in vivo function of VEGF-B, we have generated Vegfb knockout mice (Vegfb^-/-). Unlike Vegfa knockout mice, which die during embryogenesis, Vegfb^-/- mice are healthy and fertile. Despite appearing overtly normal, Vegfb^-/- hearts are reduced in size and display vascular dysfunction after coronary occlusion and impaired recovery from experimentally induced myocardial ischemia. These findings reveal a role for VEGF-B in the development or function of coronary vasculature and suggest potential clinical use in therapeutic angiogenesis. The full text of this article is available at http://www.circresaha.org.

Key Words: angiogenesis • cardiac ischemia • coronary vasculature

This article has been cited by other articles:

				A. M. Wada, S. G. Willet, and D. Bader Coronary Vessel Development: A Unique Form of Vasculogenesis Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2138 - 2145. [Abstract] [Full Text] [PDF]